Nevada case involves allegations that women developed cancer as a result of Actos medication. National network of attorneys is offering no-cost consultations to consumers seeking compensation over ...

For the second time, Takeda Pharmaceuticals is trying to fend off claims that it didn't warn Actos patients about the diabetes drug's links to bladder cancer. Earlier this year, it lost the first case ...

MT Services LLC informs plaintiffs on ongoing cases with Takeda Pharmaceutical, manufacturer of Actos (Pioglitazone hydrochloride) diabetes drug, seeking post-trial motions to lower $9Bil. verdict.

The U.S. Chamber of Commerce and others in the defense bar that filed amicus briefs in the Actos case are pushing for the U.S. Court of Appeals for the Ninth Circuit to take up class certification ...

The judge considering whether to grant a new trial after a jury returned a $9 billion verdict in the first federal Actos bellwether trial recently had several questions for the lawyers. A jury awarded ...